You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allogeneic stem cells transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

Not yet recruiting
  • Relapsed Acute Myeloid Leukaemia
  • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
  • (no location specified)
Jul 4, 2023

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Hematologic Diseases
  • allogeneic γ9δ2 T Cells
  • +3 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 23, 2023

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell

Enrolling by invitation
  • Transplantation Infection
  • +4 more
  • Intestinal microbiome new generation sequencing
  • Minsk, Belarus
    Minsk Scientific-Practical Center for Surgery, Transplantation a
Aug 28, 2022

Alterations in Intestinal Microbiota, Metabolites, and Immune

Recruiting
  • Graft Vs Host Disease
  • Blood Sample
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 16, 2023

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)

Recruiting
  • Hematologic Malignancy
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Mar 12, 2022

Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

Completed
  • Hematological Malignancies
  • CMV Infection
  • CMV-specific T cells
  • Standard anti-viral therapy
  • Gent, Oost-Vlaanderen, Belgium
  • +7 more
Dec 19, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Hematological Cancer Trial (interviews with coachs, semi-structured interviews and questionnaires, semi-structured interviews

Not yet recruiting
  • Hematological Cancer
  • interviews with coachs, semi-structured interviews and questionnaires
  • semi-structured interviews and questionnaires
  • (no location specified)
Aug 1, 2022

Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

Recruiting
  • Hematologic Diseases
  • Neoplasms
  • CD7 CAR-T cells injection
  • Allogeneic hematopoietic stem cell transplantation
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Apr 11, 2023

Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

Recruiting
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 23, 2022

Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

Not yet recruiting
  • Allogeneic Stem Cell Transplant Candidate
  • +4 more
  • Cellular therapy product
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022

Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

Recruiting
  • Acute Myeloid Leukemia
  • RC1012 injection (allo-DNT cells)
  • Hefei, Anhui, China
    The First Hospital of the University of Science and Technology o
May 17, 2023

Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki

Recruiting
  • Opportunistic Fungal Infection
  • +2 more
  • Pentavalent-specific T cells (penta-STs)
  • Patra, Greece
  • +1 more
Jul 26, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Viral Infection After HSCT Trial (Virus -specific T cells)

Not yet recruiting
  • Viral Infection After HSCT
  • Virus -specific T cells
  • (no location specified)
Mar 28, 2022

Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)

Active, not recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Feb 25, 2022

Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell

Completed
  • Cardiomyopathy
  • Heart Failure
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 11, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

Not yet recruiting
  • Steroid-refractory Acute Graft-versus-host Disease
  • MC0518
  • BAT
  • (no location specified)
Oct 4, 2023

Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cells
  • +8 more
  • Freiburg, Baden-Württemberg, Germany
  • +31 more
Jan 5, 2023